Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News Will Sarepta’s Elevidys succeed where others stalled? All eyes on EMBARK trial’s 3-year data drop Find out how Sarepta’s 3-year Elevidys trial data could reshape investor sentiment, regulatory outlook, and Duchenne gene therapy strategy. byPallavi MadhirajuJanuary 24, 2026